Guidance: Immunoglobulin: when to use

Imported from official source

Safety Classified by Officially

Further advice about post-exposure rabies treatment, supply and administration of rabies vaccine and immunoglobulin please see guidance for rabies post-exposure prophylaxis.

For guidance on the use of post-exposure prophylaxis for measles in high-risk groups please see guidance for measles post-exposure prophylaxis.

For guidance on the treatment of tetanus cases and management of tetanus prone wounds, please see tetanus: guidance for health professionals.

Post exposure prophylaxis for chickenpox and shingles

Immunoglobulins are concentrated antibody preparations that provide immediate short-term protection against disease for individuals at high risk of severe disease or serious complications from the disease.

This is an extract. The publication continues at the source.

Contains public sector information licensed under the Open Government Licence v3.0. Licence

Read the original at the source: https://www.gov.uk/government/publications/immunoglobulin-when-to-use

Officially imported this from UK Health Security Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
UK Health Security Agency — imported from official source
Official source
https://www.gov.uk/government/organisations/uk-health-security-agency.atom ATOM
Imported
October 22, 2026 12:00
Versions
1 recorded
Identity
https://www.gov.uk/government/publications/immunoglobulin-when-to-use#2026-10-22T11:14:07Z

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.